Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

reasonable argument for hysingla being inferior to Eli-200

http://www.marketwatch.com/story/elite-pharmaceuticals-releases-positive-top-line-human-abuse-liability-data-for-eli-200-an-opioid-abuse-deterrent-product-2014-09-09

The study results demonstrated statistically significant (p <.0001) lower measures of drug liking, drug high and good drug effects for Elite's manipulated (crushed) ELI-200 when compared to the manipulated (crushed) drug listed comparator product and found 91.9% of the subjects experienced increased drug liking with the comparator product compared to ELI-200 in non-dependent recreational drug users when administered intranasally.

http://www.purduepharma.com/wp-content/uploads/hysinglaerpi.pdf

Approximately 80% (n = 20) of subjects had some reduction in drug liking with tampered HYSINGLA ER relative to hydrocodone powder.